Malte Kölling

MD, PhD, Physician Scientist at Charité. ETH Zurich, University of Zurich, Hannover Medical School #CircRNA #NoncodingRNA #ChronicKidneyDisease #KidneyFibrosis

[Malte Kölling @MalteKoelling]

Incredibly honored to have received the Rainer-Greger-Promotionspreis by the German Society of Nephrology #DGFN for the best doctoral thesis in Nephrology. Big thanks to my Family and Mentors Johan Lorenzen and Thomas Thum.

[Rafael Kramann, MD PhD @rkramann]

We are thrilled to share our preprint on integrative spatial and single cell genomic analysis of human myocardial infarction https://t.co/bGPKsxLCP9 Study lead by @KuppeChristoph @roramirezf94 @ZhijianLi3 @monicahannani collaboration with @vanvanka123 @saezlab & H. Milting 1/n

[Malte Kölling @MalteKoelling]

@AnnaGreka @HarvardMITmdphd @broadinstitute @BrighamResearch @harvardmed Congratulations 🎉 👍

[Anna Greka @AnnaGreka]

What happens when Eriene Sidhom, a super-star @HarvardMITmdphd student is sent home from her clinical rotations due to COVID19? She goes back to the lab @broadinstitute @BrighamResearch @harvardmed to help in the fight! https://t.co/D5W326DQze

[Malte Kölling @MalteKoelling]

@AndrejaFigurek Thanks, Andreja 😃🙏

[Malte Kölling @MalteKoelling]

Incredibly honored to have received the Rainer-Greger-Promotionspreis by the German Society of Nephrology #DGFN for the best doctoral thesis in Nephrology. Big thanks to my Family and Mentors Johan Lorenzen and Thomas Thum.

[Malte Kölling @MalteKoelling]

@KuppeChristoph @nature @rkramann Congratulations, Christoph 👍🎉

[Malte Kölling @MalteKoelling]

Novel molecular therapeutic approach to halt the progression of diabetic kidney disease
https://t.co/woDZUvoi3A

[Rafael Kramann, MD PhD @rkramann]

I am excited to share our most recent work out in @nature today (accelerated preview) : Decoding myofibroblast origin in human kidney fibrosis. Study lead by @KuppeChristoph and Mahmoud Ibrahim @ur_fav_gene, two fellows from my lab https://t.co/eM5YP7x8hs 1/10

[Malte Kölling @MalteKoelling]

@rkramann @nature @KuppeChristoph @ur_fav_gene Congratulations, Rafael 🎉 Great work and exciting science! 👍

[Malte Kölling @MalteKoelling]

Simple actions can save lives and prevent further major restrictions for the whole society...

[Charité - Universitätsmedizin Berlin @ChariteBerlin]

#CharitéBerlin bereitet sich auf einen Anstieg von schwer erkrankten #COVID19-Patienten vor und ergreift Maßnahmen. Auch Ihr könnt Euren Beitrag leisten #flattenthecurve. Bitte schützt Euch und andere. Unsere Kolleginnen und Kollegen werden es Euch danken. 💙 #stayathome #AHAAL

[Malte Kölling @MalteKoelling]

@AndrejaFigurek @thePeerJ Congratulations 👍🎉

[Malte Kölling @MalteKoelling]

@FrancescoPaneni @snsf_ch @cmc_uzh @UZH_ch @Unispital_USZ Congratulations 🎉👍

[Malte Kölling @MalteKoelling]

DAPA-CKD with and without Type 2 Diabetes👍🎉

[European Society of Cardiology @escardio]

#DAPA-CKD trial: in patients with #CKD dapagliflozin reduced the risk of #kidney failure, reduced the risk of #cardiovascular death or #heartfailure hospitalisation, and prolonged survival https://t.co/06PiaEudZM

#ESCCongress

[Center for Molecular Cardiology @cmc_uzh]

Members of the @cmc_uzh found that DNA methylation, histone modifications and microRNAs mediate hyperglycemia-induced JunD downregulation and diabetic cardiomyopathy. @CircRes https://t.co/WGYfgVrgyM @FrancescoPaneni @UZH_en @ehj_ed #cardiotwitter @UZH_Science @TomLuscher @ehj_ed

[Malte Kölling @MalteKoelling]

@P_Enghard Congratulations, great work!

[Philipp Enghard @P_Enghard]

…proud to have our recent work on the detection of autoreactive CD4+ T cells in Lupus Nephritis published! #nephrology #Lupus #tcell
https://t.co/m3NfwO7VwD

[Michael Kaminski Lab @KaminskiLab]

Very Excited to share our new @natBME paper on #CRISPR diagnostics for opportunistic infection & acute cellular rejection in #kidney #transplant patients. Many thanks to the teams of Jim Collins @MITdeptofBE and @LVRiella @HarvardMed. Brief thread 👇 (1/6) https://t.co/gvUoHHwULf

[Malte Kölling @MalteKoelling]

@KaminskiLab @natBME @MITdeptofBE @LVRiella @harvardmed Congrats, very nice work!

[Matthew Sparks, MD @Nephro_Sparks]

Our latest in @NatRevNeph

Controversies of the renin-angiotensin system inhibition during the #COVID19 pandemic #CoronaKidney

@asouth_neph @Roxytonin @DanEdmonston @hswapnil

Thanks to the @NephJC #CovidACE2 team 🙏

https://t.co/WM9bYGhdiH

[Hans-Joachim Anders @hjanders_hans]

Farxiga Phase III DAPA-CKD trial will be stopped early after overwhelming efficacy in patients with chronic kidney disease https://t.co/uTtkrityRO